A detailed history of Cibc Asset Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Cibc Asset Management Inc holds 22,959 shares of TECH stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,959
Previous 21,241 8.09%
Holding current value
$1.64 Million
Previous $1.52 Million 20.58%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$70.96 - $82.35 $121,909 - $141,477
1,718 Added 8.09%
22,959 $1.83 Million
Q2 2024

Aug 01, 2024

SELL
$62.12 - $84.15 $60,132 - $81,457
-968 Reduced 4.36%
21,241 $1.52 Million
Q1 2024

May 09, 2024

BUY
$65.98 - $77.09 $37,674 - $44,018
571 Added 2.64%
22,209 $1.56 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $32,331 - $47,870
-612 Reduced 2.75%
21,638 $1.67 Million
Q3 2023

Oct 30, 2023

SELL
$67.52 - $89.42 $23,564 - $31,207
-349 Reduced 1.54%
22,250 $1.51 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $16,669 - $19,431
-226 Reduced 0.99%
22,599 $1.84 Million
Q1 2023

May 12, 2023

BUY
$71.62 - $86.62 $27,931 - $33,781
390 Added 1.74%
22,825 $1.69 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $1.39 Million - $6.07 Million
17,232 Added 331.19%
22,435 $1.86 Million
Q3 2022

Nov 03, 2022

BUY
$282.54 - $391.85 $128,838 - $178,683
456 Added 9.61%
5,203 $1.48 Million
Q2 2022

Aug 09, 2022

BUY
$322.67 - $449.65 $338,803 - $472,132
1,050 Added 28.4%
4,747 $1.65 Million
Q1 2022

May 06, 2022

BUY
$353.85 - $487.79 $12,738 - $17,560
36 Added 0.98%
3,697 $1.6 Million
Q4 2021

Feb 08, 2022

BUY
$456.15 - $525.06 $96,703 - $111,312
212 Added 6.15%
3,661 $1.89 Million
Q3 2021

Nov 09, 2021

BUY
$444.87 - $538.88 $895,078 - $1.08 Million
2,012 Added 140.01%
3,449 $1.67 Million
Q1 2021

May 14, 2021

SELL
$314.62 - $411.0 $22,967 - $30,003
-73 Reduced 4.83%
1,437 $549,000
Q3 2020

Nov 05, 2020

BUY
$232.22 - $282.96 $8,592 - $10,469
37 Added 2.51%
1,510 $374,000
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $18,778 - $21,986
99 Added 7.21%
1,473 $323,000
Q1 2019

May 06, 2019

BUY
$136.09 - $200.44 $186,987 - $275,404
1,374 New
1,374 $273,000
Q4 2018

Feb 12, 2019

SELL
$132.75 - $203.8 $182,398 - $280,021
-1,374 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$144.9 - $165.58 $199,092 - $227,506
1,374 New
1,374 $203,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.